O87 – 1771 Long-term simvastatin treatment for cognition and daily life in children with neurofibromatosis type 1: results from the NF1-SIMCODA trial.

Autor: van der Vaart, T, Plasschaert, E, Rietman, AB, Renard, M, Oostenbrink, R, Vogels, A, de Wit, MC, Descheemaeker, MJ, Vergouwe, Y, Catsman-Berrevoets, CE, Legius, E, Elgersma, Y, Moll, HA

Publikováno v: European Journal of Paediatric Neurology; Sep2013 Supplement, Vol. 17, pS27-S27, 1p

Autism Spectrum Disorder Symptom Profiles in Fragile X Syndrome, Angelman Syndrome, Tuberous Sclerosis Complex and Neurofibromatosis Type 1.

Autor: Lubbers K; Erasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus MC, Rotterdam, The Netherlands.; Department of Child and Adolescent Psychiatry and Psychology, Erasmus MC, Rotterdam, The Netherlands.; Child Brain Center, Erasmus MC, Rotterdam, The Netherlands., Hiralal KR; Erasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus MC, Rotterdam, The Netherlands.; Department of Child and Adolescent Psychiatry and Psychology, Erasmus MC, Rotterdam, The Netherlands.; Child Brain Center, Erasmus MC, Rotterdam, The Netherlands., Dieleman GC; Erasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus MC, Rotterdam, The Netherlands.; Department of Child and Adolescent Psychiatry and Psychology, Erasmus MC, Rotterdam, The Netherlands.; Child Brain Center, Erasmus MC, Rotterdam, The Netherlands., Hagenaar DA; Erasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus MC, Rotterdam, The Netherlands.; Department of Child and Adolescent Psychiatry and Psychology, Erasmus MC, Rotterdam, The Netherlands.; Child Brain Center, Erasmus MC, Rotterdam, The Netherlands.; Department of Pediatrics, Erasmus MC, Rotterdam, The Netherlands., Dierckx B; Erasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus MC, Rotterdam, The Netherlands.; Department of Child and Adolescent Psychiatry and Psychology, Erasmus MC, Rotterdam, The Netherlands.; Child Brain Center, Erasmus MC, Rotterdam, The Netherlands., Legerstee JS; Erasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus MC, Rotterdam, The Netherlands.; Department of Child and Adolescent Psychiatry and Psychology, Erasmus MC, Rotterdam, The Netherlands.; Child Brain Center, Erasmus MC, Rotterdam, The Netherlands.; Research Institute of Child Development and Education, University of Amsterdam, Amsterdam, The Netherlands.; Department of Child and Adolescent Psychiatry, Amsterdam University Medical Center/Levvel, Amsterdam, The Netherlands., de Nijs PFA; Erasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus MC, Rotterdam, The Netherlands.; Department of Child and Adolescent Psychiatry and Psychology, Erasmus MC, Rotterdam, The Netherlands.; Child Brain Center, Erasmus MC, Rotterdam, The Netherlands., Rietman AB; Erasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus MC, Rotterdam, The Netherlands.; Department of Child and Adolescent Psychiatry and Psychology, Erasmus MC, Rotterdam, The Netherlands.; Child Brain Center, Erasmus MC, Rotterdam, The Netherlands., Oostenbrink R; Erasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus MC, Rotterdam, The Netherlands.; Child Brain Center, Erasmus MC, Rotterdam, The Netherlands.; Department of Pediatrics, Erasmus MC, Rotterdam, The Netherlands.; Full Member of the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS)-Project ID No 739547, Amsterdam, The Netherlands., Bindels-de Heus KGCB; Erasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus MC, Rotterdam, The Netherlands.; Department of Pediatrics, Erasmus MC, Rotterdam, The Netherlands., de Wit MY; Erasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus MC, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands., Hillegers MHJ; Erasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus MC, Rotterdam, The Netherlands.; Department of Child and Adolescent Psychiatry and Psychology, Erasmus MC, Rotterdam, The Netherlands.; Child Brain Center, Erasmus MC, Rotterdam, The Netherlands., Ten Hoopen LW; Erasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus MC, Rotterdam, The Netherlands.; Department of Child and Adolescent Psychiatry and Psychology, Erasmus MC, Rotterdam, The Netherlands.; Child Brain Center, Erasmus MC, Rotterdam, The Netherlands., Mous SE; Erasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus MC, Rotterdam, The Netherlands. s.mous@erasmusmc.nl.; Department of Child and Adolescent Psychiatry and Psychology, Erasmus MC, Rotterdam, The Netherlands. s.mous@erasmusmc.nl.; Child Brain Center, Erasmus MC, Rotterdam, The Netherlands. s.mous@erasmusmc.nl.

Publikováno v: Journal of autism and developmental disorders [J Autism Dev Disord] 2024 Oct 12. Date of Electronic Publication: 2024 Oct 12.

Response to correspondence: 'Why do children with oesophageal atresia have attention problems: complications should be considered'.

Autor: van Hal ARL; Department of Paediatric Surgery, Erasmus Medical Centre Sophia Children's Hospital, Rotterdam, the Netherlands. a.r.l.vanhal@erasmusmc.nl., IJsselstijn H; Department of Paediatric Surgery, Erasmus Medical Centre Sophia Children's Hospital, Rotterdam, the Netherlands., Rietman AB; Department of Paediatric Surgery, Erasmus Medical Centre Sophia Children's Hospital, Rotterdam, the Netherlands.; Department of Child- and Adolescent Psychiatry/Psychology, Erasmus Medical Centre Sophia Children's Hospital, Rotterdam, the Netherlands.

Publikováno v: European journal of pediatrics [Eur J Pediatr] 2024 Aug; Vol. 183 (8), pp. 3631-3632. Date of Electronic Publication: 2024 May 13.

Minimally invasive surgical approach in children treated for oesophageal atresia is associated with attention problems at school age: a prospective cohort study.

Autor: van Hal ARL; Department of Paediatric Surgery, Erasmus Medical Centre Sophia Children's Hospital, Rotterdam, the Netherlands. a.r.l.vanhal@erasmusmc.nl., Vlot J; Department of Paediatric Surgery, Erasmus Medical Centre Sophia Children's Hospital, Rotterdam, the Netherlands., van Rosmalen J; Department of Biostatistics, Erasmus Medical Centre, Rotterdam, the Netherlands.; Department of Epidemiology, Erasmus Medical Centre, Rotterdam, the Netherlands., Wijnen RMH; Department of Paediatric Surgery, Erasmus Medical Centre Sophia Children's Hospital, Rotterdam, the Netherlands., van Gils-Frijters APJM; Department of Paediatric Surgery, Erasmus Medical Centre Sophia Children's Hospital, Rotterdam, the Netherlands.; Department of Child and Adolescent Psychiatry/Psychology, Erasmus Medical Centre Sophia Children's Hospital, Rotterdam, the Netherlands., Gischler SJ; Department of Paediatric Surgery, Erasmus Medical Centre Sophia Children's Hospital, Rotterdam, the Netherlands., Staals LM; Department of Anaesthesiology, Erasmus Medical Centre Sophia Children's Hospital, Rotterdam, the Netherlands., IJsselstijn H; Department of Paediatric Surgery, Erasmus Medical Centre Sophia Children's Hospital, Rotterdam, the Netherlands., Rietman AB; Department of Paediatric Surgery, Erasmus Medical Centre Sophia Children's Hospital, Rotterdam, the Netherlands.; Department of Child and Adolescent Psychiatry/Psychology, Erasmus Medical Centre Sophia Children's Hospital, Rotterdam, the Netherlands.

Publikováno v: European journal of pediatrics [Eur J Pediatr] 2024 May; Vol. 183 (5), pp. 2131-2140. Date of Electronic Publication: 2024 Feb 16.

Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials.

Autor: Müller AR; Department of Pediatrics, Emma Children's Hospital, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; 's Heeren Loo Care Group, Amersfoort, The Netherlands.; Emma Center for Personalized Medicine, Amsterdam UMC, Amsterdam, the Netherlands., den Hollander B; Department of Pediatrics, Emma Children's Hospital, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Emma Center for Personalized Medicine, Amsterdam UMC, Amsterdam, the Netherlands.; United for Metabolic Diseases, Amsterdam, The Netherlands., van de Ven PM; Department of Data Science and Biostatistics, University Medical Center Utrecht, Utrecht, The Netherlands., Roes KCB; Department of Health Evidence, Biostatistics, Radboud University Medical Center, Nijmegen, The Netherlands., Geertjens L; Child and Adolescent Psychiatry and Psychosocial Care, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands.; Amsterdam UMC, Amsterdam Neuroscience, Amsterdam Reproduction and Development, N=You Neurodevelopmental Precision Center, Amsterdam, The Netherlands., Bruining H; Emma Center for Personalized Medicine, Amsterdam UMC, Amsterdam, the Netherlands.; Child and Adolescent Psychiatry and Psychosocial Care, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands.; Amsterdam UMC, Amsterdam Neuroscience, Amsterdam Reproduction and Development, N=You Neurodevelopmental Precision Center, Amsterdam, The Netherlands.; Levvel, Center for Child and Adolescent Psychiatry, Amsterdam, The Netherlands., van Karnebeek CDM; Department of Pediatrics, Emma Children's Hospital, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Emma Center for Personalized Medicine, Amsterdam UMC, Amsterdam, the Netherlands.; United for Metabolic Diseases, Amsterdam, The Netherlands.; Department of Human Genetics, Amsterdam UMC, Amsterdam, The Netherlands., Jansen FE; Department of Pediatric Neurology, Brain, University Medical Center Utrecht, Utrecht, The Netherlands., de Wit MCY; ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands., Ten Hoopen LW; ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Child and Adolescent Psychiatry/Psychology, Sophia Children's Hospital, Erasmus University Medical Center, Rotterdam, The Netherlands., Rietman AB; ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Child and Adolescent Psychiatry/Psychology, Sophia Children's Hospital, Erasmus University Medical Center, Rotterdam, The Netherlands., Dierckx B; ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Child and Adolescent Psychiatry/Psychology, Sophia Children's Hospital, Erasmus University Medical Center, Rotterdam, The Netherlands., Wijburg FA; Department of Pediatrics, Emma Children's Hospital, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands., Boot E; 's Heeren Loo Care Group, Amersfoort, The Netherlands.; The Dalglish Family 22Q Clinic, Toronto, ON, Canada.; Department of Psychiatry & Neuropsychology, Maastricht University Medical Center, Maastricht, the Netherlands., Brands MMG; Department of Pediatrics, Emma Children's Hospital, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Emma Center for Personalized Medicine, Amsterdam UMC, Amsterdam, the Netherlands.; United for Metabolic Diseases, Amsterdam, The Netherlands., van Eeghen AM; Department of Pediatrics, Emma Children's Hospital, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands. a.m.vaneeghen@amsterdamumc.nl.; 's Heeren Loo Care Group, Amersfoort, The Netherlands. a.m.vaneeghen@amsterdamumc.nl.; Emma Center for Personalized Medicine, Amsterdam UMC, Amsterdam, the Netherlands. a.m.vaneeghen@amsterdamumc.nl.

Publikováno v: BMC psychiatry [BMC Psychiatry] 2024 Jan 04; Vol. 24 (1), pp. 23. Date of Electronic Publication: 2024 Jan 04.